COVID-19

COVID-19

FDA approves first COVID-19 drug: antiviral remdesivir

U.S. regulators on Thursday approved the first drug to treat COVID-19: remdesivir, an antiviral medicine given to hospitalized patients through an IV. The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by

COVID-19

Pandemic driving children back to work, jeopardizing gains

The coronavirus pandemic is threatening the future of a generation of the world’s children, depriving them of schooling and sending them to work. Across the developing world, two decades of gains against child labor are eroding. With classrooms shuttered and parents losing their jobs, children are trading their ABC’s for the D of drudgery: Reading,

COVID-19

Months into pandemic, Iran sees worst wave of virus deaths

Iran’s capital has run out of intensive care beds as the country confronts a new surge of infections that is filling hospitals and cemeteries alike. The single-day death toll hit a record high three times this week. Eight months after the pandemic first stormed Iran, pummeling its already weakened economy and sickening officials at the

COVID-19

Add COVID-19 to list of things driving Arizona teachers from jobs

Arizona schools have long struggled with teacher shortages but the problem was made worse this year by COVID-19, which has led to more teachers quitting or taking leave, school officials said. Just over 28% of teaching slots were still vacant several weeks into the 2020-2021 school year, up from 21% last year, according to an

Scroll to Top